Epigenetic regulation in radiation-induced pulmonary fibrosis

Int J Radiat Biol. 2023;99(3):384-395. doi: 10.1080/09553002.2022.2089365. Epub 2022 Jul 27.

Abstract

Purpose: Radiation-induced pulmonary fibrosis (RIPF) is a common and serious adverse effect of radiotherapy for thoracic tumors, which occurs in the irreversible stage of radiation-induced lung injury (RILI) >6 months after irradiation. It is characterized by progressive and irreversible destruction of lung tissue and deterioration of lung function, which may impair quality of life and lead to respiratory failure and death. We hope this will draw attention to the involvement of epigenetics in the regulation of RIPF.

Conclusions: This review summarizes research progress on the role and mechanism of DNA methylation, noncoding RNA and RNA methylation in RIPF or RILI, and the possible role and mechanism of histone modification in RIPF. We have noticed that in tissue fibrosis, the epigenetic regulation mechanisms inside and outside the nucleus can influence each other. We speculate that RIPF may be regulated by an epigenetic regulatory network during its development, and believe that TGF-β, SNAIL, PTEN and EZH2 are four targets worthy of in-depth study.

Keywords: DNA methylation; Epigenetic; Histone modification; RNA methylation; non-coding RNA; radiation-induced pulmonary fibrosis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epigenesis, Genetic
  • Fibrosis
  • Humans
  • Lung / radiation effects
  • Lung Injury* / pathology
  • Pulmonary Fibrosis* / genetics
  • Pulmonary Fibrosis* / pathology
  • Quality of Life
  • Radiation Injuries* / genetics
  • Radiation Injuries* / pathology